HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lieve Moons Selected Research

Filtering Surgery

11/2016Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery.
1/2016The Combination of PlGF Inhibition and MMC as a Novel Anti-Scarring Strategy for Glaucoma Filtration Surgery.
11/2015Complementary effects of bevacizumab and MMC in the improvement of surgical outcome after glaucoma filtration surgery.
5/2015Bevacizumab revisited: its use in different mouse models of ocular pathologies.
1/2015Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery.
1/2015Modulation of wound healing in glaucoma surgery.
1/2014Improving patient outcomes following glaucoma surgery: state of the art and future perspectives.
12/2013Inhibition of placental growth factor improves surgical outcome of glaucoma surgery.
11/2011The role of different VEGF isoforms in scar formation after glaucoma filtration surgery.
11/2009Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lieve Moons Research Topics

Disease

22Glaucoma
01/2022 - 11/2009
20Inflammation (Inflammations)
10/2021 - 04/2008
9Neoplasms (Cancer)
01/2019 - 08/2004
9Fibrosis (Cirrhosis)
12/2017 - 01/2005
7Cicatrix (Scar)
01/2019 - 11/2009
7Blister (Bulla)
11/2016 - 11/2009
6Disease Progression
11/2021 - 08/2002
5Neuroinflammatory Diseases
12/2020 - 01/2013
5Diabetic Retinopathy (Retinopathy, Diabetic)
10/2020 - 12/2015
5Choroidal Neovascularization
01/2019 - 01/2015
4Ocular Hypertension (Glaucoma, Suspect)
12/2021 - 01/2015
4Gliosis
10/2021 - 01/2019
4Alzheimer Disease (Alzheimer's Disease)
11/2020 - 05/2009
4Thrombosis (Thrombus)
12/2015 - 11/2003
4Pathologic Neovascularization
08/2013 - 07/2002
4Atherosclerosis
04/2010 - 08/2002
4Hypoxia (Hypoxemia)
02/2008 - 07/2002
3Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2019
3Optic Nerve Diseases (Optic Neuropathy)
01/2021 - 12/2015
3Optic Nerve Injuries
12/2020 - 01/2017
3Retinal Diseases
10/2019 - 12/2015
3Wounds and Injuries (Trauma)
01/2017 - 06/2013
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 09/2015
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2005 - 08/2003
2Vascular Diseases (Vascular Disease)
01/2020 - 01/2019
2Congenital Abnormalities (Deformity)
01/2020 - 02/2003
2Retinal Neovascularization
01/2019 - 03/2009
2Pathologic Processes
01/2019 - 01/2015
2Hypertension (High Blood Pressure)
01/2018 - 01/2015
2Neoplasm Metastasis (Metastasis)
06/2013 - 11/2007
2Ischemia
01/2013 - 02/2008
2Lymphedema (Milroy Disease)
09/2008 - 09/2005
2Infarction (Infarctions)
09/2008 - 03/2008
2Hypertrophy
11/2007 - 01/2005
2Heart Failure
06/2007 - 01/2005
2Ascites
01/2005 - 08/2004
1Proteostasis Deficiencies
01/2022
1Retinal Perforations
01/2022
1Crush Injuries
12/2021
1Wolfram Syndrome (Syndrome, Wolfram)
11/2021
1Sensorineural Hearing Loss
11/2021
1Macular Edema
10/2021
1Dry Eye Syndromes (Dry Eye Syndrome)
10/2020
1Peroxisomal Disorders (Peroxisomal Disorder)
06/2019

Drug/Important Bio-Agent (IBA)

19Retinaldehyde (Retinal)IBA
01/2022 - 01/2013
15Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 07/2002
11Matrix Metalloproteinases (MMPs)IBA
01/2017 - 03/2004
10CollagenIBA
12/2017 - 11/2009
7Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 01/2005
6CytokinesIBA
10/2021 - 01/2015
5Bevacizumab (Avastin)FDA Link
11/2015 - 11/2009
5rho-Associated KinasesIBA
09/2015 - 02/2014
4AntibodiesIBA
12/2015 - 08/2013
4Apolipoproteins E (ApoE)IBA
04/2010 - 03/2002
3Oxygen (Dioxygen)IBA
01/2019 - 02/2008
3Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2005
3Plasminogen Activator Inhibitor 1IBA
03/2008 - 03/2002
3ApolipoproteinsIBA
05/2005 - 03/2002
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2019
2RNA (Ribonucleic Acid)IBA
01/2022 - 10/2020
2SolutionsIBA
11/2021 - 01/2014
2Amyloid (Amyloid Fibrils)IBA
11/2020 - 09/2015
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2020 - 01/2019
2Pharmaceutical PreparationsIBA
01/2019 - 11/2016
2afliberceptIBA
01/2019 - 12/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2019 - 09/2015
2Streptozocin (Streptozotocin)FDA Link
01/2019 - 12/2017
2Fluorescein-5-isothiocyanate (FITC)IBA
01/2017 - 01/2015
2Protein Kinases (Protein Kinase)IBA
09/2015 - 08/2015
2Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
08/2015 - 08/2013
2fluorescein isothiocyanate dextranIBA
05/2015 - 01/2015
2Nerve Growth Factors (Neurotrophins)IBA
01/2015 - 01/2005
2Monoclonal AntibodiesIBA
08/2013 - 11/2009
2Protein Isoforms (Isoforms)IBA
11/2011 - 02/2003
2MorpholinosIBA
09/2008 - 09/2005
2Vascular Endothelial Growth Factor BIBA
09/2008 - 11/2007
2Plasminogen Activators (Plasminogen Activator)IBA
01/2005 - 03/2002
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2022
1LiraglutideFDA Link
11/2021
1Plasma KallikreinIBA
10/2021
1Interleukin-6 (Interleukin 6)IBA
10/2021
1ZymosanIBA
01/2021
1TrypsinIBA
10/2020
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
10/2020
1trypsin-like serine proteaseIBA
10/2020
1Serine Proteases (Serine Protease)IBA
10/2020
1MetalsIBA
10/2020
1Tyrosine (L-Tyrosine)FDA Link
01/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020
1src-Family KinasesIBA
01/2020
1Messenger RNA (mRNA)IBA
10/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1Methotrexate (Mexate)FDA LinkGeneric
01/2019

Therapy/Procedure

12Therapeutics
01/2020 - 05/2009
10Filtering Surgery
11/2016 - 11/2009
8Lasers (Laser)
01/2019 - 01/2015
5Trabeculectomy (Trabeculoplasty)
01/2014 - 11/2009
3Microspheres (Microsphere)
01/2022 - 05/2021
2Injections
10/2021 - 11/2016
2Light Coagulation
01/2016 - 01/2015